Synthesis and Biological Evaluation of N-Aryl-N’-(5-(2-hydroxybenzoyl) pyrimidin-2-yl)guanidines as Toll-Like Receptor 4 Antagonists

Author(s): Matej Sova, Kaja Rozman, Urban Svajger, Primoz Rozman, Stanislav Gobec.

Journal Name: Medicinal Chemistry

Volume 12 , Issue 8 , 2016

Become EABM
Become Reviewer

Graphical Abstract:


Background: Toll-like receptor 4 (TLR4) has been associated with several inflammatory diseases, such as sepsis, atherosclerosis and chronic pain.

Objective: The aim of the present study was to develop an efficient and straightforward synthetic approach for the preparation of small-molecule antagonists Naryl- N’-(5-(2-hydroxybenzoyl)pyrimidin-2-yl)guanidines in order to evaluate these for TLR4 antagonist activity and to obtain useful information about their structure-activity relationships.

Methods: The present work have designed and optimized a three-step synthetic route for derivatives of a previously demonstrated antagonist of TLR4: 1-(4- fluorophenyl)-2-(5-(2-hydroxy-5-methoxybenzoyl)pyrimidin-2-yl)guanidine. The antagonist activities of eight novel synthesized compounds were evaluated on cells which selectively express TLR4.

Results: Three guanidine derivatives showed promising antagonist activities, with IC50 values in the low micromolar range.

Conclusion: Our findings represent an important starting point for further studies of small-molecule agents targeting Toll-like receptors.

Keywords: Formylchromones, pyrimidines, cyanamides, guanidines, microwave-assisted synthesis, Toll-like receptor ligands.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2016
Page: [742 - 750]
Pages: 9
DOI: 10.2174/1573406412666160314151900
Price: $58

Article Metrics

PDF: 36
PRC: 1